Moreover, with accumulation of related information, it is necessary to include molecular testing beyond FISH in the future diagnostic guidelines for ALK+ NSCLC and to develop more effective strategies for management of higher-risk, V3-positive cases. Here, ALK is linked to non-small cell lung carcinoma.